• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


Run from Galderma Rx

Quote
anonymous said:
Making Nemo hard to get for IDN based docs or groups with tight links to IDNs was a very stupid idea. Have had several decline to use once they had to go outside their preferred Specialty Partner.
Click to expand...
Lol. Told Lenar this when she laid out the plan for this stupid thing. Restricted distribution will not work. David brown is equally stupid annd clueless. Wtf does a global guy know about us business. Our team is making all the classic mistakes which shows that this team has no experience. Some assholes are like it’s only been 6 weeks or 8 weeks or 10 weeks. These idiots don’t understand launch only happens once then people move on. Lenar knew she fucked up and left us with this rancid stinking shitpile. The woman sucks.
 






Can someone justify our spend in Rx right now. I have visibility into our finances and us spending > 100M on this crap is not justified. 2 cents - shuck the Aimee plan and bring in new people that actually know what the fuck they are doing. She ruined Galderma Rx and have idiots like Deb Hagan running the team. WHat is so hard here. Galderma is grat at firing people - fire these idiots and get a new team.
 




































I came to cafepharm the first time to understand more about this company. I am a dermatologist and a little weary of the info I am receiving from the company about its products. I was told at a conference if you want to learn about the company go to forums like cafepharma. I have not had the positive experience I was promised by Flemming and US leaders - syringes are broken, we don't know if the temp was maintained, drug hasnt reached on time. Itch relief is enticing but I am not sure if a first time drug launch by this company is good. Also, from what I am reading, there is a lot of dissent about leadership. Frustrating and annoying for Drs. like me.
 






I don’t have any affiliation with this company but can tell you that you should not rely on this site for anything other than the opinions of sales people looking for, involved in and/or willing to start drama. While some threads may begin with a kernel of truth, you’ll see that they usually devolve into some crazy direction.
 






anonymous said:
I don’t have any affiliation with this company but can tell you that you should not rely on this site for anything other than the opinions of sales people looking for, involved in and/or willing to start drama. While some threads may begin with a kernel of truth, you’ll see that they usually devolve into some crazy direction.
Click to expand...
Sales people on this site are mostly unhinged. Reality is that you also have more senior leaders posting on here and if you are able to recognize their messages you will find out that Galderma does indeed have an issue with its leadership an Flemming in particular. He is the one who is responsible for high employee turnover, lack of company culture and thus lack of customer care & focus, pushing sales at all cost (sorry if you have issues, defective products or are overstocked), mostly for his own benefit. Products are overall decent but Flemming is not.
 






All these posts and Nemo are beating all estimates. We got derms prescribing Nemo to patients with AD without formal approval because the drug is so good. Dupi owns the market but PBMs loves competitions for more rebates so of course they will push Nemo. This site would be a good source of information if there were some positive posts but every post about every company is a rant.
 






anonymous said:
All these posts and Nemo are beating all estimates. We got derms prescribing Nemo to patients with AD without formal approval because the drug is so good. Dupi owns the market but PBMs loves competitions for more rebates so of course they will push Nemo. This site would be a good source of information if there were some positive posts but every post about every company is a rant.
Click to expand...
I call this the Galderma paradox! Sales are doing well despite the lack of innovation and high employee turnover. Usually a strong company culture and collaborative environment is the basis for high performance. At Galderma the opposite is true.
 






Morale is low because sales targets are unattainable across all the business units. The underlying problem is EQT owns 50% of Galderma and plan to exist within the next 12 months. I'm sure you guys can deduct that extreme cost cutting and impossible growth are planned for 2025. Crazy to think that growing double digit YoY and stock up 50% since IPO in March and employees may not get bonuses. Leadership works for the shareholders and they are willing to pay a premium for top talent which is why they moved to Boston.
 






anonymous said:
All these posts and Nemo are beating all estimates. We got derms prescribing Nemo to patients with AD without formal approval because the drug is so good. Dupi owns the market but PBMs loves competitions for more rebates so of course they will push Nemo. This site would be a good source of information if there were some positive posts but every post about every company is a rant.
Click to expand...
Thank you for replying to my posts above about broken syringes and not being able to keep promises. Data on the drug looks pretty good but there’s other options. I am not sure if I can say Nemluvio is beating estimates. I only know about my office and my peers. We are all pretty frustrated. We want to prescribe but there is no coordinated message on science. I am not comfortable with what my rep has communicated. The company seems very much in it to generate NBRx and create headlines. It has been disappointing to see the lack of level on engagement from the TLLs, MSLs and Sales.
 






For the doctor commenting on here. Mind your own business. Round here we act like a n episode of Yellowstone. We don’t care about your opinion as long as the ASDs are pulling $400Gs and senior leaders are pulling 2x to that. Go away little doctor man.
 






anonymous said:
Morale is low because sales targets are unattainable across all the business units. The underlying problem is EQT owns 50% of Galderma and plan to exist within the next 12 months. I'm sure you guys can deduct that extreme cost cutting and impossible growth are planned for 2025. Crazy to think that growing double digit YoY and stock up 50% since IPO in March and employees may not get bonuses. Leadership works for the shareholders and they are willing to pay a premium for top talent which is why they moved to Boston.
Click to expand...
Something will happen to Galderma once EQT steps out (split?). Until then it’s going to be an insane pressure on generating sales and cutting even more costs. All Flemming cares about is making as much money for himself before exiting. Brace yourselves!
 






anonymous said:
Something will happen to Galderma once EQT steps out (split?). Until then it’s going to be an insane pressure on generating sales and cutting even more costs. All Flemming cares about is making as much money for himself before exiting. Brace yourselves!
Click to expand...
I have spoken to Flemming a few times at conferences. He is a Doctor and I am sure he understands the needs for patients. Is he really only money minded to let what seems like a cultural discord to fester? I guess every company has issues. What I am facing in my practice here is the fact that folks don’t know how to respond to 2nd level depth questions and it seems like all the field teams I am interacting with are giving me different messages.
 






anonymous said:
I have spoken to Flemming a few times at conferences. He is a Doctor and I am sure he understands the needs for patients. Is he really only money minded to let what seems like a cultural discord to fester? I guess every company has issues. What I am facing in my practice here is the fact that folks don’t know how to respond to 2nd level depth questions and it seems like all the field teams I am interacting with are giving me different messages.
Click to expand...
The problem starts at the head - Remove Deb Hagen. She is not fit to lead a large launch. She was a measly executive director up until 2023 and politics bitch AL brought this stupid person in. SHE DOESNAT KNOW ANYTHING and interacts with HCPs like a bumbling bafoon.
 






anonymous said:
I have spoken to Flemming a few times at conferences. He is a Doctor and I am sure he understands the needs for patients. Is he really only money minded to let what seems like a cultural discord to fester? I guess every company has issues. What I am facing in my practice here is the fact that folks don’t know how to respond to 2nd level depth questions and it seems like all the field teams I am interacting with are giving me different messages.
Click to expand...
Money is more important to Flemming then doing the right thing for the business, the workforce and even the patients. His medical ethics are non-existent in his role as CEO.
 












Top Bottom
Back
Quote